Ken Griffin Cue Biopharma, Inc. Transaction History

Citadel Advisors LLC

$483 Billion
Q2 2024

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Cue Biopharma, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 12,800 shares of CUE stock, worth $22,016. This represents 0.0% of its overall portfolio holdings.

Number of Shares

12,800

Previous 12,900 0.78%

Holding current value

$22,016

Previous $24,000 37.5%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$1.24 - $2.18 $78,069 - $137,250	-62,959 Reduced 43.05%	83,277 $103,000
Q1 2024 May 15, 2024	BUY	$1.77 - $3.09 $168,889 - $294,841	95,418 Added 187.76%	146,236 $276,000
Q4 2023 Feb 14, 2024	SELL	$1.72 - $3.1 $83,208 - $149,968	-48,377 Reduced 48.77%	50,818 $134,000
Q3 2023 Nov 14, 2023	BUY	$2.23 - $4.69 $26 - $56	12 Added 0.01%	99,195 $228,000
Q2 2023 Aug 14, 2023	SELL	$3.11 - $4.91 $20,140 - $31,797	-6,476 Reduced 6.13%	99,183 $362,000
Q1 2023 May 15, 2023	BUY	$2.41 - $3.74 $216,034 - $335,257	89,641 Added 559.63%	105,659 $377,000
Q4 2022 Feb 14, 2023	BUY	$2.39 - $3.95 $38,283 - $63,271	16,018 New	16,018 $45,000
Q2 2022 Aug 15, 2022	BUY	$2.49 - $5.92 $477,318 - $1.13 Million	191,694 Added 1552.3%	204,043 $508,000
Q1 2022 May 16, 2022	SELL	$4.41 - $12.28 $39,742 - $110,667	-9,012 Reduced 42.19%	12,349 $60,000
Q4 2021 Feb 14, 2022	SELL	$10.86 - $17.85 $4,278 - $7,032	-394 Reduced 1.81%	21,361 $0
Q2 2021 Aug 16, 2021	SELL	$10.9 - $14.53 $66,435 - $88,560	-6,095 Reduced 21.89%	21,755 $0
Q4 2020 Feb 16, 2021	SELL	$11.12 - $16.4 $2.11 Million - $3.11 Million	-189,592 Reduced 87.19%	27,850 $348,000
Q3 2020 Nov 16, 2020	SELL	$15.05 - $23.54 $834,372 - $1.31 Million	-55,440 Reduced 20.32%	217,442 $3.27 Million
Q2 2020 Aug 14, 2020	BUY	$12.7 - $30.73 $3.22 Million - $7.8 Million	253,859 Added 1334.48%	272,882 $6.69 Million
Q1 2020 May 15, 2020	BUY	$9.85 - $22.27 $187,376 - $423,642	19,023 New	19,023 $270,000

Others Institutions Holding CUE

# of Institutions

Shares Held

13.4M

Call Options Held

56.1K

Put Options Held

11.1K

View Full List

About Cue Biopharma, Inc.

Ticker CUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,381,700
Market Cap $60.9M
Description
Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders. Its lead drug candidate is CUE-101, a fusion protein biologic that is in Phase 1b clinical trial designed to target an...

More about CUE

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account